Abbisko, AstraZeneca Team Up on Lung Cancer Drug Combo After China Trial Clearance

기사 요약

Abbisko and AstraZeneca will jointly develop a Phase 1/2 NSCLC therapy combining lumipodlin with Tagrisso after China's IND clearance.